Cogniss partners with AWS ISV Accelerate Program
Sydney, Australia – 18 April 2024
Cogniss, the world’s first no-code infrastructure for patient-facing digital health, is excited to announce that it is joining the AWS ISV Accelerate Program. This significant development opens new growth avenues for the company as well as further simplifies the procurement of its infrastructure for health systems and organisations globally.
The AWS ISV Accelerate Program is designed to assist software vendors in leveraging AWS's extensive resources to boost their market presence. Through its listing on the AWS Marketplace, the Cogniss platform will become discoverable and accessible to healthcare customers from around the world.
This is yet another milestone in Cogniss’s successful partnership with Amazon Web Services (AWS). Notably the two companies, in collaboration with The Centre for Digital Transformation of Health, recently concluded the Priority Population Digital Health Challenge 2024, an initiative that seeks to support innovators in developing targeted digital health solutions for priority populations.
Joseph Barry, Chief Commercial Officer at Cogniss, said, "This is the next step in our partnership with AWS to enhance the delivery of digital health worldwide. Joining the ISV Accelerate Program broadens our reach and strengthens our capability to meet diverse healthcare needs at scale.
—
About Cogniss
Cogniss has built the world’s first no-code ecosystem for creating patient-facing and consumer-facing digital health. The platform enables healthcare experts to innovate, making it simple, quick, and affordable to build the next generation of advanced solutions – without the need for any technical expertise. Its unique point-and-click interface and 80+ pre-built widgets specifically for digital health enable the solutions to be created in days and weeks, not months and years, and at a fraction of the cost – without a team of developers.
Cogniss’s no-code ecosystem currently powers the work of several digital healthcare innovators and researchers across the UK and Australia. Learn more about Cogniss here.